Ketone Monoester Followed by Carbohydrate Ingestion after Glycogen-Lowering Exercise Does Not Improve Subsequent Endurance Cycle Time Trial Performance.

Relative to carbohydrate (CHO) alone, exogenous ketones followed by CHO supplementation during recovery from glycogen-lowering exercise have been shown to increase muscle glycogen resynthesis. However, whether this strategy improves subsequent exercise performance is unknown. The objective of this study was to assess the efficacy of ketone monoester (KME) followed by CHO ingestion after glycogen-lowering exercise on subsequent 20 km (TT20km) and 5 km (TT5km) best-effort time trials. Nine recreationally active men (175.6 ± 5.3 cm, 72.9 ± 7.7 kg, 28 ± 5 y, 12.2 ± 3.2% body fat, VO2max = 56.2 ± 5.8 mL· kg BM-1·min-1; mean ± SD) completed a glycogen-lowering exercise session, followed by 4 h of recovery and subsequent TT20km and TT5km. During the first 2 h of recovery, participants ingested either KME (25 g) followed by CHO at a rate of 1.2 g·kg-1·h-1 (KME + CHO) or an iso-energetic placebo (dextrose) followed by CHO (PLAC + CHO). Blood metabolites during recovery and performance during the subsequent two-time trials were measured. In comparison to PLAC + CHO, KME + CHO displayed greater (p < 0.05) blood beta-hydroxybutyrate concentration during the first 2 h, lower (p < 0.05) blood glucose concentrations at 30 and 60 min, as well as greater (p < 0.05) blood insulin concentration 2 h following ingestion. However, no treatment differences (p > 0.05) in power output nor time to complete either time trial were observed vs. PLAC + CHO. These data indicate that the metabolic changes induced by KME + CHO ingestion following glycogen-lowering exercise are insufficient to enhance subsequent endurance time trial performance.

Ketone Ester Supplementation Improves Some Aspects of Cognitive Function during a Simulated Soccer Match after Induced Mental Fatigue.

Ketone supplementation has been proposed to enhance cognition during exercise. To assess whether any benefits are due to reduced cognitive fatigue during the latter portions of typical sport game action, we induced cognitive fatigue, provided a ketone monoester supplement (KME) vs. a non-caloric placebo (PLAC), and assessed cognitive performance during a simulated soccer match (SSM). In a double-blind, balanced, crossover design, nine recreationally active men (174.3 ± 4.2 cm, 76.6 ± 7.4 kg, 30 ± 3 y, 14.2 ± 5.5 % body fat, V˙O2 max = 55 ± 5 mL·kg BM−1·min−1; mean ± SD) completed a 45-min SSM (3 blocks of intermittent, variable intensity exercise) consuming either KME (25 g) or PLAC, after a 40-min mental fatiguing task. Cognitive function (Stroop and Choice Reaction Task [CRT]) and blood metabolites were measured throughout the match. KME reduced concentrations of both blood glucose (block 2: 4.6 vs. 5.2 mM, p = 0.02; block 3: 4.7 vs. 5.3 mM, p = 0.01) and blood lactate (block 1: 4.7 vs. 5.4 mM, p = 0.05; block 2: 4.9 vs. 5.9 mM, p = 0.01) during the SSM vs. PLAC, perhaps indicating a CHO sparing effect. Both treatments resulted in impaired CRT performance during the SSM relative to baseline, but KME displayed a reduced (p < 0.05) performance decrease compared to PLAC (1.3 vs. 3.4% reduction in correct answers, p = 0.02). No other differences in cognitive function were seen. These data suggest that KME supplementation attenuated decrements in CRT during repeated, high intensity, intermittent exercise. More study is warranted to assess fully the potential cognitive/physical benefits of KME for athletes.

Acute Ketone Salts-Caffeine-Taurine-Leucine Supplementation but not Ketone Salts-Taurine-Leucine, Improves Endurance Cycling Performance.

Coingestion of ketone salts, caffeine and the amino acids, taurine, and leucine improves endurance exercise performance. However, there is no study comparing this coingestion to the same nutrients without caffeine. We assessed whether ketone salts-caffeine-taurine-leucine (KCT) supplementation was superior to caffeine-free ketone salts-taurine-leucine supplementation (KT), or to an isoenergetic carbohydrate placebo (CHO-PLAC). Thirteen recreationally active men (mean ± SD: 177.5 ± 6.1 cm, 75.9 ± 4.6 kg, 23 ± 3 years, 12.0 ± 5.1% body fat) completed a best effort 20-km cycling time-trial, followed 15 min later by a Wingate power cycle test, after supplementing with either KCT (approximately 7 g of beta-hydroxybutyrate, approximately 120 mg of caffeine, 2.1 g of leucine, and 2.7 g of taurine), KT (i.e., same supplement without caffeine), or isoenergetic CHO-PLAC (11 g of dextrose). Blood ketones were elevated (p < .001) after ingestion of both KCT (0.65 ± 0.12 mmol/L) and KT (0.72 ± 0.31 mmol/L) relative to CHO-PLAC (0.06 ± 0.05 mmol/L). Moreover, KCT improved (p < .003) 20-km cycling time-trial performance (37.80 ± 2.28 min), compared with CHO-PLAC (39.40 ± 3.33 min) but not versus KT (38.75 ± 2.87 min; p < .09). 20-km cycling time-trial average power output was greater with KCT (power output = 180.5 ± 28.7 W) versus both KT (170.9 ± 31.7 W; p = .049) and CHO-PLAC (164.8 ± 34.7 W; p = .001). Wingate peak power output was also greater for both KCT (1,134 ± 137 W; p = .031) and KT (1,132 ± 128 W; p = .039) versus CHO-PLAC (1,068 ± 127 W). These data suggest that the observed improved exercise performance effects of this multi-ingredient supplement containing beta-hydroxybutyrate salts, taurine, and leucine are attributed partially to the addition of caffeine.

Persistent insulin signaling coupled with restricted PI3K activation causes insulin-induced vasoconstriction.

Insulin modulates vasomotor tone through vasodilator and vasoconstrictor signaling pathways. The purpose of the present work was to determine whether insulin-stimulated vasoconstriction is a pathophysiological phenomenon that can result from a combination of persistent insulin signaling, suppressed phosphatidylinositol-3 kinase (PI3K) activation, and an ensuing relative increase in MAPK/endothelin-1 (ET-1) activity. First, we examined previously published work from our group where we assessed changes in lower-limb blood flow in response to an oral glucose tolerance test (endogenous insulin stimulation) in lean and obese subjects. The new analyses showed that the peak rise in vascular resistance during the postprandial state was greater in obese compared with lean subjects. We next extended on these findings by demonstrating that insulin-induced vasoconstriction in isolated resistance arteries from obese subjects was attenuated with ET-1 receptor antagonism, thus implicating ET-1 signaling in this constriction response. Last, we examined in isolated resistance arteries from pigs the dual roles of persistent insulin signaling and blunted PI3K activation in modulating vasomotor responses to insulin. We found that prolonged insulin stimulation did not alter vasomotor responses to insulin when insulin-signaling pathways remained unrestricted. However, prolonged insulinization along with pharmacological suppression of PI3K activity resulted in insulin-induced vasoconstriction, rather than vasodilation. Notably, such aberrant vascular response was rescued with either MAPK inhibition or ET-1 receptor antagonism. In summary, we demonstrate that insulin-induced vasoconstriction is a pathophysiological phenomenon that can be recapitulated when sustained insulin signaling is coupled with depressed PI3K activation and the concomitant relative increase in MAPK/ET-1 activity.NEW & NOTEWORTHY This study reveals that insulin-induced vasoconstriction is a pathophysiological phenomenon. We also provide evidence that in the setting of persistent insulin signaling, impaired phosphatidylinositol-3 kinase activation appears to be a requisite feature precipitating MAPK/endothelin 1-dependent insulin-induced vasoconstriction.

Hydrothermally Modified Corn Starch Ingestion Attenuates Soccer Skill Performance Decrements in the Second Half of a Simulated Soccer Match.

Hydrothermally modified non-genetically modified organisms corn starch (HMS) ingestion may enhance endurance exercise performance via sparing carbohydrate oxidation. To determine whether similar effects occur with high-intensity intermittent exercise, we investigated the effects of HMS ingestion prior to and at halftime on soccer skill performance and repeated sprint ability during the later stages of a simulated soccer match. In total, 11 male university varsity soccer players (height = 177.7 ± 6.8 cm, body mass = 77.3 ± 7.9 kg, age = 22 ± 3 years, body fat = 12.8 ± 4.9%, and maximal oxygen uptake = 57.1 ± 3.9 ml·kg BM-1·min-1) completed the match with HMS (8% carbohydrate containing a total of 0.7 g·kg BM-1·hr-1; 2.8 kcal·kg BM-1·hr-1) or isoenergetic dextrose. Blood glucose was lower (p < .001) with HMS at 15 min (5.3 vs. 7.7 mmol/L) and 30 min (5.6 vs. 8.3 mmol/L) following ingestion, there were no treatment differences in blood lactate, and the respiratory exchange ratio was lower with HMS at 15 min (0.84 vs. 0.86, p = .003); 30 min (0.83 vs. 0.85, p = .004); and 45 min (0.83 vs. 0.85, p = .007) of the first half. Repeated sprint performance was similar for both treatments (p > .05). Soccer dribbling time was slower with isoenergetic dextrose versus baseline (15.63 vs. 14.43 s, p < .05) but not so with HMS (15.04 vs. 14.43 s, p > .05). Furthermore, during the passing test, penalty time was reduced (4.27 vs. 7.73 s, p = .004) with HMS. During situations where glycogen availability is expected to become limiting, HMS ingestion prematch and at halftime could attenuate the decline in skill performance often seen late in contests.

Indicator amino acid oxidation protein requirement estimate in endurance-trained men 24 h postexercise exceeds both the EAR and current athlete guidelines.

Despite studies indicating increased protein requirements in strength-trained or endurance-trained (ET) individuals, the Institute of Medicine has concluded that "no additional dietary protein is suggested for healthy adults undertaking resistance or endurance exercise," and the controversy regarding exercise effects on protein requirements continues. The objective of this study was to determine the dietary protein requirement of healthy young ET men (≥1 yr training experience) 24 h post exercise (to minimize any acute effects of the previous training session) by measuring the oxidation of ingested l-[1-13C]phenylalanine to 13CO2 in response to graded intakes of protein (indicator amino acid oxidation technique). Eight men [maximal oxygen consumption 64.1 ml·kg-1·min-1 (SD 3.7)] were each studied 24 h postexercise repeatedly with protein intakes ranging from 0.3 to 3.5 g·kg-1·day-1. Protein was fed as an amino acid mixture based on the protein pattern in egg, except for phenylalanine and tyrosine, which were maintained at constant amounts across all protein intakes. For 2 days before the study day, all participants consumed 1.6 g protein·kg-1·day-1. The estimated average requirement (EAR) for protein was determined by applying a nonlinear mixed-effects change-point regression analysis to F13CO2 (label tracer oxidation in 13CO2 breath), which identified a breakpoint in the F13CO2 in response to the graded amounts of protein. The EAR for protein and the upper 95% confidence interval were 2.1 and 2.6 g·kg-1·day-1, respectively. These data suggest that the protein EAR for ET men 24 h postexercise exceeds the Institute of Medicine EAR and established athlete guidelines by ~3.5- and 1.3-fold, respectively.

Effects of acute and chronic interval sprint exercise performed on a manually propelled treadmill on upper limb vascular mechanics in healthy young men.

Interval sprint exercise performed on a manually propelled treadmill, where the hands grip the handle bars, engages lower and upper limb skeletal muscle, but little is known regarding the effects of this exercise modality on the upper limb vasculature. We tested the hypotheses that an acute bout of sprint exercise and 6 weeks of training induces brachial artery (BA) and forearm vascular remodeling, favoring a more compliant system. Before and following a single bout of exercise as well as 6 weeks of training three types of vascular properties/methodologies were examined in healthy men: (1) stiffness of the entire upper limb vascular system (pulse wave velocity (PWV); (2) local stiffness of the BA; and (3) properties of the entire forearm vascular bed (determined by a modified lumped parameter Windkessel model). Following sprint exercise, PWV declined (P < 0.01), indices of BA stiffness did not change (P ≥ 0.10), and forearm vascular bed compliance increased and inertance and viscoelasticity decreased (P ≤ 0.03). Following manually propelled treadmill training, PWV remained unchanged (P = 0.31), indices of BA stiffness increased (P ≤ 0.05) and forearm vascular bed viscoelasticity declined (P = 0.02), but resistance, compliance, and inertance remained unchanged (P ≥ 0.10) compared with pretraining values. Sprint exercise induced a more compliant forearm vascular bed, without altering indices of BA stiffness. These effects were transient, as following training the forearm vascular bed was not more compliant and indices of BA stiffness increased. On the basis of these data, we conclude that adaptations to acute and chronic sprint exercise on a manually propelled treadmill are not uniform along the arterial tree in upper limb.

Energy intake over 2 days is unaffected by acute sprint interval exercise despite increased appetite and energy expenditure.

A cumulative effect of reduced energy intake, increased oxygen consumption, and/or increased lipid oxidation could explain the fat loss associated with sprint interval exercise training (SIT). This study assessed the effects of acute sprint interval exercise (SIE) on energy intake, subjective appetite, appetite-related peptides, oxygen consumption, and respiratory exchange ratio over 2 days. Eight men (25 ± 3 years, 79.6 ± 9.7 kg, body fat 13% ± 6%; mean ± SD) completed 2 experimental treatments: SIE and recovery (SIEx) and nonexercise control. Each 34-h treatment consisted of 2 consecutive 10-h test days. Between 0800-1800 h, participants remained in the laboratory for 8 breath-by-breath gas collections, 3 buffet-type meals, 14 appetite ratings, and 4 blood samples for appetite-related peptides. Treatment comparisons were made using 2-way repeated measures ANOVA or t tests. An immediate, albeit short-lived (<1 h), postexercise suppression of appetite and increase in peptide YY (PYY) were observed (P < 0.001). However, overall hunger and motivation to eat were greater during SIEx (P < 0.02) without affecting energy intake. Total 34-h oxygen consumption was greater during SIEx (P = 0.04), elicited by the 1491-kJ (22%) greater energy expenditure over the first 24 h (P = 0.01). Despite its effects on oxygen consumption, appetite, and PYY, acute SIE did not affect energy intake. Consequently, if these dietary responses to SIE are sustained with regular SIT, augmentations in oxygen consumption and/or a substrate shift toward increased fat use postexercise are most likely responsible for the observed body fat loss with this type of exercise training.

Incorporating sprint training with endurance training improves anaerobic capacity and 2,000-m Erg performance in trained oarsmen.

A 2,000-m time-trial performance, aerobic capacity, and anaerobic capacity were assessed in 16 trained oarsmen after sprint interval training (SIT) replaced a portion of an endurance-based training program (EBTSIT) vs. an endurance-based program alone (EBTAlone). The EBTSIT involved 10 SIT sessions over 4 weeks, in addition to 12 continuous exercise sessions, 2 anaerobic threshold exercise sessions, and 4 strength training sessions. The EBTAlone consisted of 20 continuous, 6 anaerobic threshold, 2 interval exercise sessions, and 8 strength training sessions. Time-trial performance (2,000-m erg performance) improved with EBTSIT (baseline = 414.6 ± 18.5, post = 410.6 ± 17.5 seconds; p < 0.001) but only approached significance in EBTAlone (baseline = 413.0 ± 27.7, post = 411.4 ± 27.9 seconds; p = 0.06). In a 60-second "all-out" anaerobic capacity test, peak power output (PPO) increased significantly with EBTSIT (PPO: EBTSIT: baseline = 566 ± 82, post = 623 ± 60 W; p = 0.02) but not with EBTAlone (EBTAlone: baseline = 603 ± 81, post = 591 ± 123 W; p = 0.59). Changes in average power output (APO) also approached significance (p = 0.07) (APO: EBTSIT: baseline = 508 ± 48, post = 530 ± 52 W; EBTAlone: baseline = 532 ± 55, post = 533 ± 68 W). Neither group experienced any change in aerobic capacity ((Equation is included in full-text article.)or ventilatory threshold; p ≥ 0.16). We conclude that replacing a portion of EBT with SIT can improve both 2,000-m erg performance and anaerobic capacity, while maintaining aerobic fitness in trained oarsmen. Incorporating SIT within endurance training programs may be useful during periods of low-volume training, to improve performance without sacrificing aerobic capacity.

Running sprint interval training induces fat loss in women.

Data on whether sprint interval training (SIT) (repeated supermaximal intensity, short-duration exercise) affects body composition are limited, and the data that are available suggest that men respond more favourably than do women. Moreover, most SIT data involve cycling exercise, and running may differ because of the larger muscle mass involved. Further, running is a more universal exercise type. This study assessed whether running SIT can alter body composition (air displacement plethysmography), waist circumference, maximal oxygen consumption, peak running speed, and (or) the blood lipid profile. Fifteen recreationally active women (age, 22.9 ± 3.6 years; height, 163.9 ± 5.1 cm; mass, 60.8 ± 5.2 kg) completed 6 weeks of running SIT (4 to 6, 30-s "all-out" sprints on a self-propelled treadmill separated by 4 min of rest performed 3 times per week). Training decreased body fat mass by 8.0% (15.1 ± 3.6 to 13.9 ± 3.4 kg, P = 0.002) and waist circumference by 3.5% (80.1 ± 4.2 to 77.3 ± 4.4 cm, P = 0.048), whereas it increased fat-free mass by 1.3% (45.7 ± 3.5 to 46.3 ± 2.9 kg, P = 0.05), maximal oxygen consumption by 8.7% (46 ± 5 to 50 ± 6 mL/(kg·min), P = 0.004), and peak running speed by 4.8% (16.6 ± 1.7 to 17.4 ± 1.4 km/h, P = 0.026). There were no differences in food intake assessed by 3-day food records (P > 0.329) or in blood lipids (P > 0.595), except for a slight decrease in high-density lipoprotein concentration (1.34 ± 0.28 to 1.24 ± 0.24 mmol/L, P = 0.034). Running SIT is a time-efficient strategy for decreasing body fat while increasing aerobic capacity, peak running speed, and fat-free mass in healthy young women.

Addition of synchronous whole-body vibration to body mass resistive exercise causes little or no effects on muscle damage and inflammation.

The purpose of this study was to determine if a moderate intensity whole-body vibration (WBV) body mass resistive exercise session causes additional muscle damage, soreness, and inflammation compared with the same exercise session without vibration (NoV). Ten recreationally active male university students completed 2 separate 24-hour study periods incorporating an exercise session with WBV or NoV. Muscle torque was measured (at 0, 60, and 240°·s-1 angular velocities), soreness (10-point scale) in the upper (UE [triceps]) and lower (LE [quadriceps]) extremities, and muscle inflammation markers (interleukin [IL]-1ß, IL-6, IL-10) were measured at 4 time points (preexercise, immediately postexercise, 4 hours post, and 24 hours post). Diet was controlled. Compared with NoV, WBV increased (p < 0.01) muscle soreness at 24 hours postexercise in both the UE (2.2 ± 1.7 vs. 0.6 ± 0.9) and LE (2.0 ± 1.5 vs. 0.7 ± 0.7). Muscle torque was decreased immediately postexercise (p < 0.05) in the UE and LE at 0°·s and in the UE at 240°·s, but there was no difference between exercise treatments. The exercise session caused significant but small increases in IL-1ß and IL-6 but with no differences between exercise treatments. Interleukin-10 was increased with WBV (2.9 ± 2.0 to 3.6 ± 1.9 pg·ml-1; p < 0.03). These data suggest that the addition of WBV to exercise has little effect on muscle function and damage, soreness, or inflammation.

Synchronous whole-body vibration increases VO2 during and following acute exercise.

Single bout whole-body vibration (WBV) exercise has been shown to produce small but significant increases in oxygen consumption (VO(2)). How much more a complete whole-body exercise session (multiple dynamic exercises targeting both upper and lower body muscles) can increase VO(2) is unknown. The purpose of this study was to quantify VO(2) during and for an extended time period (24 h) following a multiple exercise WBV exercise session versus the same session without vibration (NoV). VO(2) of healthy males (n = 8) was measured over 24 h on a day that included a WBV exercise session versus a day with the same exercise session without vibration (NoV), and versus a control day (no exercise). Upper and lower body exercises were studied (five, 30 s, 15 repetition sets of six exercises; 1:1 exercise:recovery ratio over 30 min). Diet was controlled. VO(2) was 23% greater (P = 0.002) during the WBV exercise session versus the NoV session (62.5 ± 12.0 vs. 50.7 ± 8.2 L O(2)) and elicited a higher (P = 0.033) exercise heart rate versus NoV (139 ± 6 vs. 126 ± 11 bpm). Total O(2) consumed over 8 and 24 h following the WBV exercise was also increased (P < 0.010) (240.5 ± 28.3 and 518.9 ± 61.2 L O(2)) versus both NoV (209.7 ± 22.9 and 471.1 ± 51.6 L O(2)) and control (151.4 ± 20.7 and 415.2 ± 51.6 L O(2)). NoV was also increased versus control (P < 0.003). A day with a 30-min multiple exercise, WBV session increased 24 h VO(2) versus a day that included the same exercise session without vibration, and versus a non-exercise day by 10 and 25%, respectively.

Run sprint interval training improves aerobic performance but not maximal cardiac output.

UNLABELLED: Repeated maximal-intensity short-duration exercise (sprint interval training, SIT) can produce muscle adaptations similar to endurance training (ET) despite a much reduced training volume. However, most SIT data use cycling, and little is known about its effects on body composition or maximal cardiac output (Qmax). PURPOSE: The purpose of this study was to assess body composition, 2000-m run time trial, VO(2max), and Q(max) effects of run SIT versus ET. METHODS: Men and women (n = 10 per group; mean ± SD: age = 24 ± 3 yr) trained three times per week for 6 wk with SIT, 30-s all-out run sprints (manually driven treadmill), four to six bouts per session, 4-min recovery per bout, versus ET, 65% VO(2max) for 30 to 60 min·d(-1). RESULTS: Training improved (P < 0.05) body composition, 2000-m run time trial performance, and VO(2max) in both groups. Fat mass decreased 12.4% with SIT (mean ± SEM; 13.7 ± 1.6 to 12.0 ± 1.6 kg) and 5.8% with ET (13.9 ± 1.7 to 13.1 ± 1.6 kg). Lean mass increased 1% in both groups. Time trial performance improved 4.6% with SIT (-25.6 ± 8.1 s) and 5.9% with ET (-31.9 ± 6.3 s). VO(2max) increased 11.5% with SIT (46.8 ± 1.6 to 52.2 ± 2.0 mL·kg·(-1)·min(-1)) and 12.5% with ET (44.0 ± 2.0 to 49.5 ± 2.6 mL·kg·(-1)·min(-1)). None of these improvements differed between groups. In contrast, Q(max) increased by 9.5% with ET only (22.2 ± 2.0 to 24.3 ± 1.6 L·min(-1)). CONCLUSIONS: Despite a fraction of the time commitment, run SIT induces similar body composition, VO(2max), and performance adaptations as ET, but with no effect on Q(max). These data suggest that adaptations with ET are of central origin primarily, whereas those with SIT are more peripheral

10 or 30-s sprint interval training bouts enhance both aerobic and anaerobic performance.

We assessed whether 10-s sprint interval training (SIT) bouts with 2 or 4 min recovery periods can improve aerobic and anaerobic performance. Subjects (n = 48) were assigned to one of four groups [exercise time (s):recovery time (min)]: (1) 30:4, (2) 10:4, (3) 10:2 or (4) control (no training). Training was cycling 3 week(-1) for 2 weeks (starting with 4 bouts session(-1), increasing 1 bout every 2 sessions, 6 total). Pre- and post-training measures included: VO(2max), 5-km time trial (TT), and a 30-s Wingate test. All groups were similar pre-training and the control group did not change over time. The 10-s groups trained at a higher intensity demonstrated by greater (P < 0.05) reproducibility of peak (10:4 = 96%; 10:2 = 95% vs. 30:4 = 89%), average (10:4 = 84%; 10:2 = 82% vs. 30:4 = 58%), and minimum power (10:4 = 73%; 10:2 = 69%; vs. 30:4 = 40%) within each session while the 30:4 group performed ~2X (P < 0.05) the total work session(-1) (83-124 kJ, 4-6 bouts) versus 10:4 (38-58 kJ); 10:2 (39-59 kJ). Training increased TT performance (P < 0.05) in the 30:4 (5.2%), 10:4 (3.5%), and 10:2 (3.0%) groups. VO(2max) increased in the 30:4 (9.3%) and 10:4 (9.2%), but not the 10:2 group. Wingate peak power kg(-1) increased (P < 0.05) in the 30:4 (9.5%), 10:4 (8.5%), and 10:2 (4.2%). Average Wingate power kg(-1) increased (P < 0.05) in the 30:4 (12.1%) and 10:4 (6.5%) groups. These data indicate that 10-s (with either 2 or 4 min recovery) and 30-s SIT bouts are effective for increasing anaerobic and aerobic performance.

Vertical whole-body vibration does not increase cardiovascular stress to static semi-squat exercise.

The purpose of this study was to determine the effect of vertical whole-body vibration (WBV) on heart rate (HR), mean arterial pressure (MAP), femoral artery blood flow (FBF), and leg skin temperature (LSk(temp)) during static exercise. These parameters were examined: seated next to the WBV device (passive, unloaded), with feet secured onto the WBV platform (knees 90 degrees flexion) and while standing in a semi-squat position (static, loaded, knees 120 degrees flexion); both with and without WBV. Conditions involved 1 min bouts separated by 1 min rest, repeated 15 times followed by 10 min recovery. WBV in the seated condition had no effect on the responses examined. The static semi-squat without WBV increased MAP 9 mmHg (P < 0.05) with no significant effect on HR, FBF, or LSk(temp). Similarly, WBV static semi-squat increased MAP 8-14 mmHg (P < 0.05), FBF 135-180 mL/min, and LSk(temp) 1.8-3.1 degrees C (P < 0.05). However, only the LSk(temp) was increased above the no-WBV semi-squat position (P < 0.05). The addition of WBV to repeated intermittent static semi-squats does not appear to be a significant cardiovascular stressor.

Reliability of air displacement plethysmography in a large, heterogeneous sample.

INTRODUCTION: Several studies have assessed the validity of air displacement plethysmography (ADP), but few have assessed the reliability of ADP using a large, heterogeneous sample. PURPOSE: This study was conducted to determine the reliability of ADP using the Bod Pod in a large, heterogeneous sample. METHODS: A total of 980 healthy men and women (30 +/- 15 yr, mean +/- SD) completed two body composition assessments separated by 15-30 min. All testing was done in accordance with the manufacturer's instructions. RESULTS: A significant correlation (r = 0.992, P = 0.001) was found between body density (BD) 1 (1.046 +/- 0.001 kg.L(-1); mean +/- SEM) and BD 2 (1.046 +/- 0.001 kg.L(-1). A paired t-test revealed no significant difference between BD 1 and 2 (P = 0.935). The coefficient of variation (CV) for BD was 0.15%. A significant intraclass correlation coefficient (ICC) was found for BD (ICC = 0.996, P = 0.001), and the standard error of measurement (SEM) was 0.001 kg.L(-1). Body mass (BM) 1 and 2 were correlated significantly (r = 0.999, P = 0.001); however, a significant (P = 0.001) decrease was seen from BM 1 (75.510 +/- 0.461 kg) to BM 2 (75.497 +/- 0.461 kg). Body volume (BV) tended to decrease (P = 0.08) from BV 1 (69.900 +/- 0.449 L) to BV 2 (69.884 +/- 0.449 L). CONCLUSION: ADP using the Bod Pod appears to assess BD reliably; however, the observed CV suggests that multiple trials are necessary to detect small treatment effects.

Postexercise muscle glycogen recovery enhanced with a carbohydrate-protein supplement.

PURPOSE: This study assessed whether liquid carbohydrate-protein (C+P) supplements, ingested early during recovery, enhance muscle glycogen resynthesis versus isoenergetic liquid carbohydrate (CHO) supplements, given early or an isoenergetic solid meal given later during recovery (PLB). METHODS: Two hours after breakfast (7.0 kcal.kg; 0.3 g.kg P, 1.2 g.kg C, 0.1 g.kg F), six male cyclists performed a 60-min time trial (AMex). Pre- and postexercise, vastus lateralis glycogen concentrations were determined using nMRS. Immediately, 1 h, and 2 h postexercise, participants ingested C+P (4.8 kcal.kg; 0.8 g.kg C, 0.4 g.kg P), CHO (4.8 kcal.kg; 1.2 g.kg C), or PLB (no energy). Four hours postexercise, a solid meal was ingested. At that time, C+P and CHO received a meal identical to breakfast, whereas PLB received 21 kcal.kg (1 g.kg P, 3.6 g.kg C, 0.3 g.kg F); energy intake during 6 h of recovery was identical among treatments. After 6 h of recovery, measurement and cycling protocols (PMex) were repeated. RESULTS: Absolute muscle glycogen utilization was 18% greater (P

Dietary creatine supplementation and exercise performance: why inconsistent results?

Over the past few years there has been considerable interest in both the use of creatine (Cr) supplementation by athletes and the documentation of its effects by scientists. Some believe that this nitrogen-containing compound found in meat and fish has a performance-enhancing capability as important for brief intense exercise efforts as dietary carbohydrate is for activities where glycogen supplies limit performance. The mechanisms thought to be responsible for any ergogenic effect of acute (few d) Cr supplementation include: increased stores of muscle phosphocreatine (PCr), faster regeneration of PCr during exercise recovery, enhanced adenosine triphosphate (ATP) production from glycolysis secondary to increased hydrogen ion buffering, and/or possible shortened post contraction muscle relaxation time. With chronic (wk mo) supplementation when combined with strength training, Cr may alter muscle protein metabolism directly (via decreasing protein breakdown or increasing synthesis) and/or indirectly as a result of a greater training load made possible by its acute ergogenic effects on strength and power. Cr supplementation is not banned by the International Olympic Committee and, with the exception of a small increase in body mass (approximately 1 kg) over the initial 36 d, does not appear to have any adverse side effects, at least with short-term use. Few scientific data are available for more prolonged use (mo or y) but considering the large numbers of athletes using Cr over the past 6+ y and the absence of reported problems, it may be that the often discussed somewhat nebulous long term adverse effects are presently being overestimated. Intakes of 285-300 mg Cr/kg body mass 1 over 36 d or 3050 mg/kg body mass 1 over approximately 4 wk are sufficient to produce benefits (muscle mass and high intensity power gains); however, not all study results are consistent. The focus of this review is to outline some possible explanations for the inconsistent observations reported in the literature. Clearly, if proven to be consistent the benefits of Cr supplementation could extend far beyond the athletic arena to include individuals who experience muscle weakness for a variety of other reasons (e.g., age/disuse, muscle disease, exposure to microgravity, etc).

The role of protein and amino acid supplements in the athlete's diet: does type or timing of ingestion matter?

Rather than the age-old debate regarding overall protein and amino acid needs of athletes, this paper focuses on the importance of timing and type of protein and amino acid ingestion relative to both muscle growth and exercise performance. Evidence discussed comes from definitive measurement techniques including net protein balance determinations (for acute studies) or quantification of muscle size or strength (for chronic studies) First, recent data indicate that consuming a small meal of mixed macronutrient composition (or perhaps even a very small quantity of a few indispensable amino acids) immediately before or following strength exercise bouts can alter significantly net protein balance, resulting in greater gains in both muscle mass and strength than observed with training alone. With aerobic exercise, some evidence suggests immediate postexercise (but perhaps not pre-exercise) supplementation is also beneficial. Second, protein type may also be important owing to variable speeds of absorption and availability, differences in amino acid and peptide profiles, unique hormonal response, or positive effects on antioxidant defense. In addition to athletes, many others who desire to regain, maintain, or enhance muscle mass or function, including those with muscle-wasting diseases, astronauts, and all of us as we age, need to ensure that nutrient availability is sufficient during the apparently critical anabolic window of time associated with exercise training sessions. Future studies are needed to fine tune these recommendations.